Validity and Reliability of The Indonesian Version of Patient Allergic Rhinitis Questionnaire and Allergic Rhinitis Prevalence in A Class Of 2018-2019 Medical Students of Universitas Padjadjaran, Indonesia

Sheila Rafifah Yuliantoputri, Melati Sudiro, Arif Dermawan, Lina Lasminingrum, Sally Mahdiani

Abstract


Objective: To determine the validity and reliability of the Indonesian version of Patient Allergic Rhinitis Questionnaire as a screening tool for AR and the prevalence of AR in a class of 2018-2019 medical students of Universitas Padjadjaran, Indonesia.

Methods: A cross-sectional descriptive study was performed during the period November-December 2021 on a class of 2018-2019 medical students of Padjadjaran University. The Indonesian version of the pre-validated Patient Allergic Rhinitis Questionnaire was distributed online. Allergic rhinitis was determined from history taking by identifying a history of a previous diagnosis of AR and/or 2 or more symptoms (watery runny nose, sneezing, nasal congestion, itching, or conjunctivitis) for more than 1 hour on most days.

Results:. The validity of the Indonesian version of the Patient Allergic Rhinitis Questionnaire was good with a 0.895 Cronbach's Alpha coefficient, reflecting a reliable questionnaire. The prevalence of AR was 35.8% with most were female (69.2%). There were 59.9% of respondents who had a history of allergy in their parents. The most common symptom was nasal congestion (85.7%) and the moderate-severe persistent (49.2%) was the most common ARIA-WHO classification. Dusty places (92.1%) were the most common cause of symptoms. The most common comorbidity was rhinosinusitis (35%). The mean symptom severity score was 6.7.

Conclusions: The Indonesian version of the Patient Allergic Rhinitis Questionnaire is valid and reliable as a screening tool for AR. The prevalence of AR in this study is quite high, with moderate-severe persistent as the most prominent classification.


Keywords


Allergic rhinitis, patient allergic rhinitis questionnaire, prevalence, reliability, validity

Full Text:

PDF

References


  1. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization , GA 2 LEN * and AllerGen **). Allergy. 2008;63(Suppl 86):8–160.
  2. Brozek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-anticevich S, et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines—2016 revision. J Allergy Clin Immunol. 2017;140(4):950–8.
  3. Pawankar R, Canonica GW, Holgate ST, Lockey RF, Blaiss MS, editors. World Allergy Organization (WAO) White Book on Allergy: Update 2013. Milwaukee: WAO; 2013. 1–240 p.
  4. Feng M, Tsai Y, Chang Y. Allergic rhinitis as a key factor for the development of gastroesophageal reflux disease in children. J Microbiol Immunol Infect. 2021;54(6):1167–74.
  5. Pham D Le, Trinh THK, Le K, Pawankar R. Characteristics of allergen profile, sensitization patterns and allergic rhinitis in SouthEast Asia. Curr Opin Allergy Clin Immunol 2022 Apr;22(2):137–42.
  6. Fauzi, Sudiro M, Lestari BW. Prevalence of allergic rhinitis based on World Health Organization (ARIA-WH) questionnaire among Batch 2010 Students of the Faculty of Medicine Universitas Padjadjaran. Althea Med J. 2015;2(4):620–5.
  7. Sudiro M, Madiadipoera THS, Purwanto B. Eosinofil kerokan mukosa hidung sebagai diagnostik rinitis alergi nasal scrapping eosinophil as a diagnostic test for allergic rhinitis. Maj Kedokt Bandung. 2010;42(1):6–11.
  8. Levy DML. Audit: Allergic Rhinitis and Asthma [Internet]. Available from: http://www.guideline-audit.com/allergic_rhinitis/.
  9. Varma S. Preliminary item statistics using point-biserial correlation and p-values. 2006. [Internet]. Available from: https://jcesom.marshall.edu/media/24104/Item-Stats-Point-Biserial.pdf
  10. Taber KS. The Use of Cronbach’s Alpha When Developing and Reporting Research Instruments in Science Education. 2018;1273–96.
  11. Ha J, Lee SW, Yon DK. Ten-year trends and prevalence of asthma, allergic rhinitis, and atopic dermatitis among the Korean population, 2008 –2017. Clin Exp Pediatr. 2020;63(7):278–83.
  12. Ozoh OB, Aderibigbe SA, Ayuk AC, Desalu OO, Oridota OE, Olufemi O, et al. The prevalence of asthma and allergic rhinitis in Nigeria: A nationwide survey among children, adolescents and adults. PLoS One. 2019;14(9):e0222281.
  13. Passalacqua G. Allergic rhinitis in women. Futur Med. 2007;3(5):603–11.
  14. Acharya D, Bajgain BB, Yoo S. Factors associated with atopic dermatitis and allergic rhinitis among Residents of two municipal areas in South Korea. Medicina (B Aires). 2019;55(5):1–8.
  15. Sudiro M, Lestari BW, Madiadipoera T, Setiabudiawan B, Boesoirie TS. Vitamin D deficiency is correlated with severity of allergic rhinitis. Open Access Libr J. 2017;4(e3813).
  16. Basyir P, Madiadipoera T, Lasminingrum L. Angka kejadian dan gambaran rinitis alergi dengan komorbid otitis media di poliklinik rinologi alergi Departemen Ilmu Kesehatan THT-KL RS Dr . Hasan Sadikin. Tunas Medika Jurnal Kedokteran Kesehatan. 2016;3(1)1–7.
  17. Bjermer L, Westman M, Holmström M, Wickman MC. The complex pathophysiology of allergic rhinitis: Scientific rationale for the development of an alternative treatment option. Allergy Asthma Clin Immunol. 2019;15(1):1–15.
  18. Jean P, Demoly P, Mesbah K. Impact of allergic rhinitis symptoms on quality of life in primary Care. 2013;5:393–400.
  19. Hoffmans R, Wagemakers A, Van Drunen C, Hellings P, Fokkens W. Acute and chronic rhinosinusitis and allergic rhinitis in relation to comorbidity, ethnicity, and environment. PLoS One. 2018;13(2):1–14.
  20. Moeis RM, Sudiro M, Herdiningrat RBS. Allergic rhinitis patient characteristics in Dr. Hasan Sadikin General Hospital Bandung Indonesia. AMJ. 2014;1(2):75–80.




DOI: https://doi.org/10.15850/ijihs.v10n1.2711

Article Metrics

Abstract view : 783 times
PDF - 388 times



 

This Journal indexed by

                   

 


Creative Commons License
IJIHS is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License



View My Stats